Login

Financial Snapshot

Revenue
TTM
$1.291B
Gross Margin
TTM
81.17%
Net Income
TTM
$251.0M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
85.62%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
-$144.0M
Cash
2026 Q1
P/E
TTM
17.21
Free Cash Flow
TTM
-$193.0M

Stock Price

Loading...
Market Cap: $4.3197 Billion

About Indivior Pharmaceuticals, Inc

The filing excerpts provided for Indivior Pharmaceuticals, Inc (INDV) do not contain sufficient substantive business content to generate a SEC-grounded company description. The available excerpts consist of SEC cover page boilerplate, a table of contents, and share count references, none of which disclose the company's core business activity, revenue model, products, customers, geographic footprint, competitors, or financial results. A description cannot be constructed from these materials without relying on outside knowledge, which the source-grounding rules prohibit.

Source: SEC 10-K, filed 2026-02-26

Industry: Pharmaceutical Preparations Peers: Verona Pharma plc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support